VivoSim Labs, INC. — Director's Dealing 2021

Oct 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2021-10-07

Reporting Person: Murphy Keith (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-07	Stock Option (Right to Buy)	$6.70	A	60000	Acquired	2031-10-07	Common Stock (60000)	Direct
2021-10-07	Stock Option (Right to Buy)	$6.70	A	60000	Acquired	2031-10-07	Common Stock (60000)	Direct
2021-10-07	Stock Option (Right to Buy)	$6.70	A	17500	Acquired	2031-10-07	Common Stock (17500)	Direct

Footnotes

F1: The option becomes exercisable, if at all, if the 45-day moving average closing price of the Issuer's common stock on The Nasdaq Stock Market LLC exceeds $30.00 per share.

F2: The option becomes exercisable, if at all, if the 45-day moving average closing price of the Issuer's common stock on The Nasdaq Stock Market LLC exceeds $35.00 per share.

F3: The option shares shall vest and become exercisable on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders.